Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41582-020-0368-9 http://scihub22266oqcxt.onion/10.1038/s41582-020-0368-9 C7242886!7242886 !32444648     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32444648 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Nat+Rev+Neurol 2020 ; 16 (7 ): 347-348 Nephropedia Template TP {{tp|p=32444648 |t=2020. COVID-19 and management of neuroimmunological disorders |pdf=|usr=}}{{32444648 }} gab.com Text COVID-19 and management of neuroimmunological disorders JO: Nat Rev Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32444648 #FOAvip The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological disease. Twit Text FOAVip COVID-19 and management of neuroimmunological disorders ????Nat Rev Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32444648 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32444648 #FOAvip English Wikipedia <ref>{{Cite pmid|32444648 }}</ref> COVID-19 and management of neuroimmunological disorders #MMPMID32444648 Hartung HP ; Aktas O Nat Rev Neurol 2020[Jul]; 16 (7 ): 347-348 PMID32444648 show ga The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological disease. |*Betacoronavirus [MESH] |*Disease Management [MESH] |COVID-19 [MESH] |Coronavirus Infections/epidemiology/*immunology/*therapy [MESH] |Humans [MESH] |Immunotherapy/methods [MESH] |Nervous System Diseases/epidemiology/*immunology/*therapy [MESH] |Neuroimmunomodulation/physiology [MESH] |Pandemics [MESH] |Pneumonia, Viral/epidemiology/*immunology/*therapy [MESH]COVID-19 and management of neuroimmunological disorders (epmc).pdf DeepDyve Pubget Overpricing